Andersen will cease to be a Nominated Advisor (NomAd) for companies listed on the London Stock Exchange's fledgling market, the Alternative Investment Market (AIM), if the embattled Big Five firm's proposed merger with Deloitte & Touche goes ahead. But Andersen have only just got round to discussing the implications of the merger with its AIM clients.
Tom Berry, 30 Apr 2002
